Back

Accuracy of event rate and effect size estimation in major cardiovascular trials

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular epidemiology & trial design Trial Design ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Associate Professor Christoph Olivier

University of Freiburg, Freiburg (Germany)

5 More presentations in this session

Presentation thumbnail
Medication adherence assessment and reporting in cardiovascular randomised controlled trials
Doctor Z. Ashkir (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
AT-RISK: AuToimmune disorders and cardiovascular RISK.
Doctor N. Conrad (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry
Doctor V. Arevalos Rivas (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
The REALITY project: analysis of a national database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain.
Professor V. Barrios (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Development of a risk prediction score and equation for chronic kidney disease: A retrospective cohort study
Doctor S. Kawasoe (Kagoshima, JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular epidemiology & trial design

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Bioresorbable scaffolds revisited
thumbnail
Congress Session
Cardiology Toolbox - Clinical trial design
thumbnail
Congress Presentation
New levels of evidence for therapy and prevention in ESC Guidelines: why? what? how?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources